Epithelial differentiation including tight junction (TJ) formation occurs exclusively within the trophectoderm (TE) lineage of the mouse blastocyst. Here we examine mechanisms by which TJ protein membrane assembly might be regulated by protein kinase C (PKC) in the embryo. To overcome the inherent staging asynchrony of individual blastomeres within intact embryos, we have used isolated inner cell masses (ICMs) from early blastocysts to induce epithelial differentiation in their outer cells responding to their new cell contact pattern. Two TJ proteins examined retain their order of membrane assembly in isolated ICMs in culture as during normal development (early-assembling ZO-2 and late-assembling ZO-1a 1 ), but this process is highly accelerated. Using six chemical modulators of PKC activity, we show here that PKC signalling is involved in the regulation of TJ membrane assembly. While indolactam-mediated PKC activation stimulates membrane assembly of both TJ proteins, TPAmediated PKC activation stimulates only that of ZO-1a 1 . The PKC inhibitors Ro-31-8220, Ro-31-8425 and Gö 6983 suppress the stimulatory effect of both PKC activators on membrane assembly to varying extents according to inhibitor and TJ protein examined. Gö 6983 similarly inhibits ZO-2 and ZO-1a 1 membrane assembly. PKC inhibition by Gö 6976 appeared to stimulate TJ membrane assembly. Despite the broad PKC isotype specificity of the inhibitors used, these data suggest that the two TJ proteins are differently regulated by PKC isotypes or subfamilies. As Gö 6983 uniquely affects aPKC (particularly PKCz) and we find that both PKCd and z relocate upon activator treatment to co-localise partially with the TJ proteins in isolated ICMs, we suggest that at least PKCd and z may play a central role in regulating TJ membrane assembly.
Introduction
Mammalian preimplantation development is driven by a spatially and temporally controlled gene expression programme regulating cell multiplication and differentiation. In the mouse, the newly activated embryonic genome coordinates the processes that upregulate epithelial differentiation in the outer trophectoderm (TE) layer of the blastocyst and suppress such differentiation in the pluripotent inner cell mass (ICM) (Fleming et al. 2001 , Watson & Barcroft 2001 . To generate a functional TE, these cells must engage in transepithelial transport driven by basolateral Na þ /K þ -ATPase to create the blastocoel cavity while at the same time acquiring intercellular junctional adhesion to maintain epithelial integrity and provide a permeability seal against blastocyst collapse.
TE differentiation is established gradually over three cell cycles and begins at compaction (eight-cell stage) when blastomeres become adhesive and polarised following activation of E-cadherin (reviewed in Fleming et al. 2001 ). Subsequently, differentiative divisions generate outer polarised and inner non-polarised progenitors of TE and ICM lineages respectively at the 16-cell morula stage before further division to the 32-cell stage, when differentiation is completed and the blastocyst forms (Johnson & Ziomek 1981 , Fleming 1987 , Fleming et al. 2001 . During this period, apicolateral zonula adherens (ZA), tight junctions (TJ) and lateral membrane desmosomes are gradually assembled exclusively within outer polarised cells. At the TJ, the intracellular plaque proteins ZO-1a 2 and rab13 assemble first at the eight-cell stage and cingulin plaque protein at the 16-cell stage, followed by the transmembrane protein occludin and the second isoform of ZO-1, ZO-1a þ , at the 32-cell stage (Fleming et al. 1989 , Sheth et al., 1997 , 2000a . The ZO-2 plaque protein also assembles at the 16-cell stage (B. Sheth, unpublished) . After initiation of cavitation, desmosomes form during the 32-cell stage, comprising transmembrane desmocollin (DSC2) and the cytoplasmic protein desmoplakin, and stabilise epithelial cohesion (Fleming et al. 1991 , Collins et al. 1995 . During cleavage, adherens junctions (AJ) form in both ICM and TE lineages of the blastocyst (Ohsugi et al. 1997) .
The underlying molecular mechanisms that coordinate the establishment of cell phenotype divergence in the blastocyst remain poorly understood. One major regulator of blastocoel formation is the release of intracellular calcium, partly mediated via G-protein-coupled receptors (Stachecki et al. 1994 , Stachecki & Armant 1996a ,b, Wang et al., 1998 . During TE differentiation, membrane assembly of the majority of TJ components appears to be regulated by translation (Javed et al. 1993 ) and/or posttranslational modifications (such as phosphorylation) rather than de novo transcription (Fleming & Hay 1991) , since transcripts for TJ proteins are readily detectable within the ICM of the early blastocyst (Sheth et al., 1997 (Sheth et al., , 2000a . For example, occludin appears to require posttranslational changes in order to become competent for membrane insertion at the TJ in embryos (Sheth et al., 2000a) . ZO-1a þ , however, may be an exception, since it is transcribed just prior to cavitation and may regulate completion of TJ membrane assembly and cavitation (Sheth et al., 1997 (Sheth et al., , 2000a . Within models that already represent a differentiated epithelial cell phenotype, such as Madin-Darby canine kidney (MDCK) cells, transcription is generally not required for the assembly, maintenance and function of TJs, while activation of protein kinase C (PKC) is required, suggesting the occurrence of post-translational modifications (Ellis et al. 1992 , Denisenko et al. 1994 , Stuart & Nigam 1995 see also Denker & Nigam 1998 , Mullin et al. 1998 Matter & Balda 1999 , Suzuki et al., 2001 , Tsukita et al. 2001 , Brag 2002 , Hurd et al. 2003 . Moreover, occludin and ZO-2 are reported to be direct targets for PKC phosphorylation in vitro (Andreeva et al. 2001 , Avila-Flores et al. 2001 .
Although activation of PKC has been shown to be involved in the regulation of oocyte maturation, fertilisation and compaction, whether it has a role during TE differentiation remains unclear (Winkel et al. 1990 , Pauken & Capco 1999 , Capco 2001 . There are at least 11 different PKC isoforms (conventional or cPKCa, bI, bII and g; novel or nPKCd, e, h, u and m; and atypical or aPKCi/l and z) with different structure and activation requirements (Mochly-Rosen & Gordon 1998; Csukai & Mochly-Rosen 1999) , and a variety of these have been detected throughout preimplantation embryo development (Gangeswaran & Jones 1997 , Raz et al. 1998 , Pauken & Capco 2000 , Downs et al. 2001 . Moreover, expression and localisation of several isoforms appears to be developmentally regulated (Pauken & Capco 2000, Eckert et al. unpublished) .
In the present study, we examine mechanisms by which TE differentiation and TJ protein membrane assembly might be governed by PKCs. However, due to the inherent asynchrony in developmental rates between individual blastomeres within intact embryos, targeting treatment to modulate PKC activity to specific differentiative events becomes problematic. To overcome this concern, we have used the isolated ICM model in which immunosurgery acts as an experimentally controllable 'switch' to induce TE-like differentiation of outer blastomeres released from the inhibitory condition of cell contact symmetry experienced in the embryo interior (Fleming et al. 2001 ). Thus, for example, ICMs show ZO-1 membrane assembly within hours of isolation and form blastocyst-like vesicles with TE-like differentiation of the outer cells when isolated from early blastocysts, while ICMs isolated from later, more expanded blastocysts preferentially form endodermlike structures (Handyside 1978 , Spindle 1978 , Rossant & Lis 1979 , Fleming et al., 1984 , Nichols & Gardner 1984 , Chisholm et al., 1985 , Fleming & Hay 1991 . In addition, the ICM model concentrates on the effect of (post-) translational events rather than transcriptional influences, since the TJ transcripts are already present within the ICM. For example, isolated ICMs were used to show that initiation and stabilisation of cell polarisation may involve posttranslational modification of ezrin, a cell-surface protein that mediates membrane-cytoskeletal interaction (Louvet-Vallee et al. 2001) . Moreover, the justification for investigating developmental mechanisms using isolated ICMs has been indicated by their capacity to implant into the uterus (Rossant & Lis 1979) and develop into offspring when injected into host blastocysts (Azim et al. 1978) .
In examining the isolated ICM model, our data, using a pharmacological approach with broad PKC specificity, show that PKC signalling is involved in regulation of membrane assembly of both TJ components ZO-2 and ZO-1a þ and also suggest the involvement of different PKC isotype networks for each TJ component. While modulation of PKC activity with broad chemical inhibitors and activators does not allow conclusive unravelling of the identity of the PKC isoforms involved, our results indicate a role for PKCd and z in TJ assembly. They also clearly demonstrate the complexity of the signalling cascades used by the early embryo to coordinate properly the assembly of a multimolecular complex such as a TJ during TE differentiation.
Materials and Methods

Embryo collection and culture
Embryos were collected from MF1 female mice (University of Southampton Biomedical Facility) after superovulation by intraperitoneal injection of 5 i.u. pregnant mare's serum (PMS; Folligon, Intervet UK Ltd, Milton Keynes, UK) followed by 5 i.u. human gonadotrophin (hCG; Chorulon, Intervet) and mating 48 h later. Eight-cell embryos were flushed from dissected oviducts with H6 medium supplemented with 4 mg/ml BSA (H6-BSA; Sigma) and cultured under our standard conditions up to the early blastocyst stage in T6 medium containing 4 mg/ml BSA (T6-BSA), in 5% CO 2 in air atmosphere at 37 8C, in microdrops under oil (J.M. Loveridge, Southampton, UK), as described previously (Sheth et al., 1997 , 2000a ,b, Louvet-Valleee et al. 2001 .
Isolation and culture of ICMs
ICMs were isolated in batches of 100-150 from early blastocysts (92 -96 h after hCG; maximum of 2 h after the formation of a visible cavity) to ensure TE-like differentiation (Fleming et al. 1984 , Chisholm et al. 1985 by immunosurgery, as previously described (Sheth et al. 1997 ) with modifications (Van Soom et al. 1996 . After removal of the zona pellucida by acid Tyrode's, blastocysts were incubated in 10 nM trinitrobenzene-sulphonic acid (TNBS; Sigma) in H6 medium containing 3 mg/ml PVP (Sigma, H6-PVP) (Sheth et al. 1997) for 10 min at room temperature to mark the outer TE cells. TNBS combines with Nterminal amines and thus labels proteins and some phospholipids. After extensive washing in H6-PVP, blastocysts were incubated for 10 min at room temperature in 0.3% goat anti-dinitrophenyl-antibody (anti-DNP-BSA; ICN Biochemicals (Basingstoke, Hampshire, UK); cross-reacts with trinitrophenol-groups) in H6-PVP, before three thorough washes in H6-PVP, and 10-min incubation in human (Sigma) or guinea pig (Cedarlane Laboratories Ltd, Hornby, ON, Canada) complement, reconstituted according to the manufacturer and diluted 1:10 in H6-BSA at 37 8C. Finally, after a 20-min recovery of the treated embryos in H6-BSA, the ICMs were shelled out mechanically with a thinly pulled and polished micropipette. The freshly isolated ICMs were placed in 500 ml DMEM (Gibco) plus 10% FCS (heat-inactivated; Labtech International, Rigmer, Sussex, UK) in four-well plates (Nunc, Roskilde, Denmark) and incubated at 5% CO 2 in air and 37 8C in a humidified atmosphere for up to 29 h before fixation.
Immunocytochemistry and confocal microscopy
Zona-free embryos or ICMs were fixed in PBS supplemented with 1% formaldehyde (Analar, Merck, Poole, Dorset, UK or Sigma) for 7 -15 min, attached onto cover slips coated with 1.5 mg/ml poly-L-lysine hydrobromide (Sigma) and processed for immunocytochemistry as described previously (Fleming et al. 1991 , Sheth et al., 1997 , 2000a . For all experiments, each cover slip contained isolated ICMs and 2 -3 intact control blastocysts to ensure staining efficiency. The embryos/ICMs were stained overnight at 4 8C with the different primary antibodies, as described below, at the appropriate dilutions. A set of cross-purified ALEXA-488-, ALEXA-546-or ALEXA-568labelled anti-mouse, anti-rabbit or anti-rat secondary antibodies (Molecular Probes, Cambridge Bioscience, Oxford, UK) was used at dilutions of 1:500 either alone or in combinations for double-labelling experiments for 1 h at room temperature. After three final washes and mounting with an antifading agent (Citifluor in PBS; Citifluor Ltd, Leicester, UK), specimens were visualised with a £ 63 oil-immersion Nikon inverted microscope linked to a Bio-Rad MRC-600 series confocal imaging system, equipped with a kryptonargon laser. Images were analysed and processed by the Bio -Rad software system (Confocal Assistant, Version 4.01). The staining pattern for junctional proteins in isolated ICMs was judged as negative if no staining was detected within cell membranes, discontinuous if only certain membrane areas showed dotted linear staining, or continuous if all membrane areas contained linear staining (see Fig. 1 ). The discontinuous pattern was seen as an intermediate state of membrane assembly.
Antibodies and verification of staining patterns
Antibodies to the junctional protein ZO-1a þ (rabbit polyclonal, diluted 1:250, or guinea pig polyclonal, diluted 1:250, both against the murine a-motif; Sheth et al., 1997) were diluted in PBS and used as previously described. The antibody to ZO-2 (rabbit polyclonal, diluted 1:1000) was purchased from Zymed. The staining for PKC isoforms was performed with in-house polyclonal antibodies against the rat sequences, as detailed elsewhere (Drew et al. 1994 , Gott et al. 1994 , Littlebury et al. 1997 , at dilutions between 1:200 and 1:500 (Eckert et al. unpublished). These in-house antibodies were analysed by Western blotting and showed similar protein sizes for PKCbI, bII, g, d, e and z in mouse liver and/or brain lysates, as described previously (Drew et al. 1994 , Gott et al. 1994 , Littlebury et al. 1997 ) (data not shown). Preincubation with the respective peptide against which they were raised blocked immunofluorescent staining either partially or completely.
For further verification of the specificity of these antibodies, a set of commercial antibodies generated in mouse (Transduction Labs, BD Bioscience, Oxford, UK) or rabbit (PKCz, Sigma) against the various PKC isoforms was used in parallel at the appropriate dilutions (1:100-1:300 and 1:1000 for PKCz respectively). The commercial antibodies have been used previously in different species or mouse embryos (e.g. Minichiello et al. 1999 , Pauken & Capco 2000 . Negative controls (secondary antibody only; rabbit pre-immune serum, neat) did not show background staining. Respective negative controls for the double labelling (successive incubation in respective primary antibodies at room temperature for 1 h instead of simultaneous incubation in antibody-cocktail; cross-controls with one primary and two secondary or two primary and one secondary antibody) ensured that there was no cross-reactivity between different primary and secondary antibodies. The staining pattern was identical with both sets of PKC isotype-specific antibodies.
Chemical PKC activation and inhibition
Isolated ICMs were cultured in the presence of 0.1, 1, or 10 nM of the cell-permeable PKC activators TPA (phorbol ester; Calbiochem-Novachem Ltd, Nottingham, UK) or indolactam (alkaloid-type activator; Calbiochem), or 10 nM 4aPDD (inactive analogue; Calbiochem) or 0.1% DMSO (vehicle; Sigma) as controls. Both activators directly affect cPKCs and nPKCs, but while TPA preferably binds the calcium-dependent cPKC isoforms ) indolactam binds to cPKC and nPKC subtypes without preference , Lee et al. 1993 , Geiges et al. 1997 . After 1, 2 or 3 h (n ¼ 34 -57 per time point, treatment and antibody) or 6 h (n ¼ 15 -38 per treatment and antibody), the ICMs were fixed and stained in parallel for ZO-2 or ZO-1a þ to determine the capacity for membrane insertion of an 'early' and a 'late' assembling TJ protein. For each time point, data were collected from at least five replicate experiments (that is, different batches of embryos).
Isolated ICMs were also cultured in the presence of the cell-permeable protein kinase inhibitors Gö 6976 (indolocarbazole; 100 or 10 nM), Gö 6983, Ro-31-8220 or Ro-31-8425 (bisindolylmaleimides; 1 mM or 100 nM; all from Calbiochem) for 1 h before fixation and staining for ZO-2 or ZO-1a þ . In parallel, ICMs were first incubated in inhibitor for 15 min, washed three times, and then incubated for the remaining 45 min in the presence of either PKC activator to examine the reversibility of inhibitor treatment (n ¼ 38 -60 per treatment and antibody in five replicate experiments). The inhibitor was washed out before activator treatment to avoid interaction between the two chemicals. These protein kinase inhibitors inhibit PKC at nanomolar concentrations (100-1000-fold more efficient for PKC than, for example, for PKA) and can be effective within minutes of treatment within other systems (Staendart et al. 1997 , Lin & Chen 1998 , Keller et al. 2000 . The inhibitors have been shown to affect a broad range of PKC isoforms with slightly varying efficiency (summarised in Way et al. 2000) . For example, Gö 6076 has been used to inhibit cPKCs over nPKCs, and it uniquely affects PKCm at nanomolar concentrations, while Gö 6983 is the only inhibitor among the ones tested that affects PKCz (see Table 1 and references therein).
Activator (10 nM) and inhibitor (10 nM for Gö 6976 and 100 nM for the other inhibitors) treatments for 1 h were also followed by staining for PKC isotypes (n ¼ 19 -25 per treatment and antibody in 3 -5 replicate 
Statistical analysis
With the SigmaStat software package (Jandel Scientific, San Rafael, CA, USA), a general linear model was used to test for interactions between treatment and staining pattern for PKC or TJ proteins in the PKC activator -inhibitor experiments. A two-way ANOVA followed by Tukey's test or a two-way ANOVA on ranks followed by Dunn's test where appropriate was used to identify significant differences. Differences were considered as significant if P , 0.05.
Results
Activation of PKC stimulates TJ protein membrane assembly in isolated ICMs
Fixation and staining for the two TJ proteins ZO-2 and ZO-1a þ established that, like the sequence within the intact embryo, ZO-2 assembles earlier than ZO-1a þ in isolated ICMs, with a clear distinction between the two up to 6 h after onset of in vitro culture. For example, at 1, 2 and 6 h after ICM isolation, ZO-2 continuous membrane assembly was observed in 25%, 26%, and 71% (n ¼ 35 -45) respectively, while ZO-1a þ membrane assembly was observed in 2%, 5% and 33% (n ¼ 37 -50) of ICMs stained. After overnight culture, some 80% of ICMs showed membrane assembly of these proteins, indicative of their viability (Fig. 1 ). Moreover, recavitation was first observed after 9 h of culture in a small percentage of isolated ICMs (1 -3%; n ¼ 112), but, by 14 h, 70% had recavitated.
To establish whether PKC signalling is involved in regulating junction membrane assembly in our developmental model, we investigated the effect of two different PKCspecific activators, TPA and indolactam, on the membrane assembly of ZO-2 and ZO-1a þ in cultured isolated ICMs (Fig. 2) . Overall, continuous membrane assembly of both TJ proteins was accelerated (see Materials and Methods and Fig. 1 for definition; Fig. 2A and B) , while discontinuous staining was minimally affected (not shown; deduced from Fig. 2) . This stimulation was observed after a short culture period only and most potently with indolactam (1-2 h for ZO-2 and 2-3 h for ZO-1a þ ). Due to increasing spontaneous continuous membrane assembly of both TJ proteins (significant shift towards the continuous pool in all treatment groups), the stimulatory effects of PKC activators became undetectable after 6 h. Specificity of the effects was confirmed, as the inactive TPA analogue 4aPDD did not affect TJ assembly rate in any case.
The two activators had different effects that depended upon dosage, time point, and TJ protein examined ( Fig. 2A  and B ). Continuous membrane assembly of ZO-2 was not significantly elevated compared with the controls at any time point by TPA treatment. However, a rapid (1 h) and significant (P , 0.05) shift of ZO-2 from the negative towards the continuous pool was observed in all concentrations of TPA. Indolactam appeared more potent than TPA, as increasing doses rapidly (1 h) and significantly (P , 0.05) elevated membrane assembly of ZO-2 in continuous pools by decreasing the discontinuous and negative pools. For the later assembling protein, ZO-1a þ , all concentrations of TPA significantly (P , 0.05) reduced the negative pool by shifting ZO-1a þ towards the discontinuous and/or continuous pools. While the highest 10 nM dose was most potent in this respect early on (2 h), lower doses became more effective later (3-6 h), suggesting dose-dependent downregulation when higher doses of TPA were used. In contrast, the lowest dose of indolactam (0.1 nM indolactam) was most potent to reduce significantly (P , 0.05) the negative pool of ZO-1a þ in favour of continuous membrane assembly early on (2 h), and the middle dose was the most potent after 3 h.
Inhibition of PKC activation differentially affects TJ protein membrane assembly in isolated ICMs
To confirm the specificity of PKC action and to elucidate which PKC isotypes might be involved, four PKC-specific inhibitors with slightly different isotype-specific inhibitory efficiency (see Methods and Methods; Table 1) were used at two different concentrations. These treatment groups were compared with vehicle control (DMSO), minimal effective dose of activator alone (TPA: 10 nM for ZO-1a þ , indolactam: 10 nM for ZO-2 and 0.1 nM for ZO-1a þ ; derived from Fig. 2) , and inhibitor followed by activator treatment (Fig. 3A and B) to examine the reversibility of inhibitor treatment. To minimise variable and (potentially) non-specific effects of drug treatment, culture time was restricted to 1 h when activator effects had been obvious previously (see above). Non-specific toxicity of drug treatment was excluded, as 60 -80% of ICMs derived from each treatment group (n ¼ 20 -30) recavitated after culture in drug-free medium for an additional 12 h.
Overall, again the discontinuous pool of TJ membrane assembly remained similar, and mainly the distribution between the continuous and negative staining pools was changed. Moreover, the lower inhibitor concentrations showed more severe inhibition than the higher concentrations, as the majority of ICMs remained within the negative staining pool. As with the activators, the effects of different inhibitors varied between the two TJ proteins examined. In the case of ZO-2, due to a high and rapid spontaneous membrane assembly in this experimental series, the effect of indolactam alone remained slightly below significance level compared to vehicle control (P ¼ 0.058). The opposite was observed in the case of ZO-1a þ . The low spontaneous membrane assembly occurring within the time frame of 1 h used in this experimental series was not further reduced by any inhibitor type or concentration but was significantly (P , 0.05) increased by both activator treatments. Ro-31-8220 prevented (P , 0.05) activator-induced membrane assembly of both ZO-2 and ZO-1a þ in a dose-and activator-typedependent manner, while Ro-31-8425 inhibited only TPA-induced ZO-1a þ membrane assembly. TPA-induced continuous membrane assembly of ZO-1a þ was more effectively prevented by both inhibitors compared to indolactam-induced membrane assembly. Furthermore, most ICMs remained within the discontinuous pool of ZO-1a þ staining rather than the negative one (deduced from Fig.  3 ), suggesting that these inhibitors could not prevent the initiation of membrane assembly (discontinuous staining), but only its completion (continuous staining), during this time frame of 1 h. However, the most potent inhibitor of membrane assembly of both TJ proteins induced by both activator types was Gö 6983, which appeared to reduce both initiation and completion of membrane assembly of both TJ proteins, with the majority of ICMs remaining within the negative pool. Notably, a speckled intracellular staining pattern for ZO-2 was observed in 80% of ICMs examined in all five replicates (Fig. 4) . This pattern could also be seen occasionally (2/5 replicates) in the presence of Ro-31-8220 in approximately 30% of the ICMs investigated, and could only partially be overcome by indolactam-induced activation. The inhibitor Gö 6976 did not have any significant effect (P . 0.05) on either the rapid spontaneous or indolactam-induced ZO-2 membrane assembly. Surprisingly, similar continuous ZO-2 membrane assembly levels were observed as compared to indolactam activation, as also evidenced by a significant shift towards the continuous pool. In the case of ZO-1a þ , Gö 6976 stimulated the low spontaneous membrane assembly, although this was slightly less evident when followed by the respective activator treatment. Results are summarised in Table 1 .
Specific PKC isotypes relocate in ICMs after isolation and after activation or inhibition of PKC
To help identify the candidate PKC isotypes potentially involved in membrane assembly of TJ proteins in isolated and cultured ICMs, we next examined the localisation of PKC isotypes either immediately following isolation, or after culture for 1 h in the presence of either vehicle control, the two activators (10 nM), or the lower concentration of one of the inhibitors. Isolated ICMs were both fixed immediately after isolation or after 1 h in culture and stained for different isoforms (Fig. 5A and B) . Two factors determine biologically relevant activity of PKCs: the accessibility of their substrate binding site and their subcellular distribution. Both are in turn regulated by second messengers, specific anchoring proteins and the phosphorylation status of PKCs (Mochly-Rosen & Gordon 1998 , Jaken & Parker 2000 , Newton 2003 . When many PKC isoforms are present within the same cell, a change in localisation reflecting altered accessibility of the kinase to protein substrates is indicative of a change in activation status and function in response to a certain event -in this case, ICM isolation and culture. The cPKCs (Fig. 5B) and PKCh (not shown) remained diffusely located within the cytoplasm in freshly isolated or cultured ICMs in all treatment groups. The novelrelated isoform PKCm also did not change location over time in any treatment group (Fig. 5B) . In contrast, nPKCe, d and u, and aPKCz and i/l changed their distribution pattern in ICMs after isolation, but a high variation of treatment effects was observed according to isotype (Fig. 5A and B) . While PKCe was found distributed diffusely within the cytoplasm of freshly isolated ICMs, it appeared to be concentrated at the membrane or as a combination of membrane and focal cytoplasmic staining (Fig. 5B ) within outer blastomeres in ICMs cultured for 1 h (P , 0.05; Fig. 5A ). As expected, PKCe remained significantly (P , 0.05) more within the cytoplasm when cultured in the presence of Ro-31-8220 and Ro-31-8425, the two inhibitors reportedly affecting this isoform. PKCd, u, z and i/l were already located within the membrane of approximately 25 -83% ( Fig. 5A and B) of freshly isolated ICMs, while ICMs within intact blastocysts showed no membrane staining for any of these isotypes (not shown; Eckert et al. unpublished) . This suggested a very rapid (within minutes of handling time) relocation towards the ICM membrane region upon provision of a contact-free cell surface for these isoforms. However, PKCd and z showed a tendency (P , 0.1; Fig. 5A ) to relocate increasingly towards the membrane region in isolated ICMs during the 1-h incubation period. As expected, PKCd was shifted to the membrane by both activators (P , 0.01 and P , 0.05 respectively) while PKCz was significantly (P , 0.01) increased within the membrane pool upon TPA, but not indolactam, activation. However, none of the inhibitors had any significant effect on the localisation of these two isotypes.
On the other hand, PKCi/l was significantly (P , 0.01) increased within the cytoplasmic pool by Gö 6976, an inhibitor not reported to affect this PKC isotype. Finally, PKCu rapidly relocated towards the membrane in the controls, but this was even more pronounced in the presence of both activators and all four inhibitors (P , 0.01-0.05).
To examine a possible interaction between PKC isotypes and TJ proteins during membrane assembly, isolated ICMs cultured with activators or inhibitors were doublelabelled with ZO-1a þ and the different PKCs. A close proximity was found between the TJ protein ZO-1a þ and PKCz, i/l, u or d in the membrane region of blastomeres after 1-h culture in vitro in all treatments, such that in some domains colocalisation was evident but in other areas the two proteins were separately located ( Fig. 6 shows double-labelling for ZO-1a þ and PKCd).
Discussion
In the present study, we have used the isolated ICM model for reformation of TE epithelial differentiation to examine the role of PKC isotypes in TJ biogenesis. Collectively, our results from investigating the effects of broad PKC activators and inhibitors on TJ protein membrane assembly and PKC isotype localisation demonstrate for the first time that PKCs regulate this process under our culture conditions in vitro. The switch in cell contact patterns experienced by ICM cells following immunosurgery thus appears to activate PKCs to mediate this step in differentiation.
In vitro cultured ICMs isolated from early blastocysts within the first few hours after formation of a visible cavity develop a TE-like outer cell layer with polarised cytoplasm and TJs resembling a miniature blastocyst (Fleming et al. 1984 , Chisholm et al. 1985 , Fleming & Hay 1991 . This miniature blastocyst can induce a decidual reaction upon embryo transfer, further confirming TE-like identity of the outer cells (Rossant & Lis 1979) . The capacity to recavitate and reform TE-like outer cells is progressively lost when ICMs are isolated from older, more expanded blastocysts, which then form predominantly endoderm-like structures (Fleming et al. 1984 , Chisholm et al. 1985 . In the present study using cultured ICMs isolated from very early blastocysts (within 2 h of cavitation), we further demonstrate the suitability of this model to examine underlying mechanisms of TJ protein membrane assembly. Our confocal microscopy time course shows that both TJ proteins examined kept their characteristic membrane assembly timing as during normal development (ZO-2 early and ZO-1a þ late). However, the acceleration of assembly from three cell cycles to one cell cycle helped overcome the problem of exact timing of developmental stage and asynchrony. Cell adhesion (E-cadherin) and cytoskeleton (F-actin) remained unchanged in cultured ICMs (not shown; Louvet-Vallee et al. 2001) , and it has been shown previously that in this model polarisation of outer cells, including microvilli-formation, takes place as in normal development (Fleming et al. 1984 , Louvet-Vallee et al. 2001 . Our results and those of others confirm the notion that reversal of the cell contact symmetry within the ICM in intact blastocysts releases the suppression of TJ protein membrane assembly, and illustrate the capacity of the ICM to compensate rapidly and repair potential cellular loss in the outer TE wall (see Introduction; reviewed in Fleming et al. 2001) . Moreover, a number of PKC isoforms redistribute rapidly within ICMs during isolation from the blastocyst (discussed below). During compaction and cavitation of intact embryos, changes of PKC distribution have similarly been shown, and certain PKC isoforms are distributed in a lineage-specific manner within the nascent blastocyst (Pauken & Capco 2000, Eckert et al. unpublished) . However, we cannot exclude the possibility that in vitro culture methods may influence any of these processes.
In the present study, stimulation of PKC activity by either the phorbol ester, TPA (which activates only the cPKCs and nPKCs and preferably binds the calciumdependent cPKC isoforms; Kazanietz et al. 1993) or the alkaloid-type activator, (2 )-indolactam V (which binds to cPKC and nPKC subtypes without preference; Kazanietz et al. 1993 , Lee et al. 1993 , Geiges et al. 1997 , showed a dose-and time-dependent acceleration of membrane assembly dependent upon the TJ protein examined. PKC activator treatment was most effective during shorter incubation times and was no longer evident after 6-h culture. This may suggest that, by 6 h, those ICMs that will recavitate within the next few hours (indicating reformation of predominantly TE) have accomplished TJ membrane assembly (approximately 55 -70% show assembly, corresponding to an approximately 70% cavitation rate a few hours later respectively), and PKC activation cannot further increase this percentage. Alternatively, the activator may have caused downregulation of the activity of certain PKC isoforms. This has been widely reported previously as a consequence of longer-term exposure and/or high concentrations of TPA (e.g. Ellis et al. 1992) . To avoid this effect, the concentrations of phorbol ester used in our study were well below those that induced downregulation or inhibited compaction as reported previously by others (Bloom 1989 , Winkel et al. 1990 ). In addition, only a short-term exposure to the drugs was employed to avoid other side effects on embryo development (Ohsugi & Yamamura 1993) .
Modulation of PKC activity had different effects for the two TJ protein markers examined. While assembly of ZO-1a þ was readily stimulated by both activators, although with different potency, ZO-2 assembly was stimulated by indolactam and at a higher concentration than that required for ZO-1a þ while TPA had only marginal effects. This distinction may in part reflect the rapidity of ZO-2 assembly in controls compared with ZO-1a þ , making further stimulation more difficult to induce. Alternatively, different PKC isotypes may be involved for each TJ protein. The latter idea is supported further by the variable capacity of different inhibitors to prevent spontaneous and/or activator-induced membrane assembly within a restricted time frame. For example, the broad cPKC and nPKC inhibitor Ro-31-8425 reduced TPA-induced membrane assembly of ZO-1a þ , but not that of ZO-2. On the other hand, Ro-31-8220, which is another broad inhibitor reaching cPKCs and nPKCs with similar efficiency as Ro-31-8425, prevented activator-induced and/or spontaneous upregulation of membrane assembly of both TJ proteins. This surprising discrepancy may be explained by the fact that only Ro-31-8220 has been shown to inhibit also aPKCs (PKCz; Staendart et al. 1997 ), although at a much higher concentration than the one used in the present study. Involvement of aPKCs in TJ membrane assembly is indicated further by very efficient inhibition of membrane assembly of both proteins in the presence of Gö 6983, an inhibitor reaching cPKCs and nPKCs, like Ro-31-8425 and Ro-31-8220, but also inhibiting aPKCz more potently than Ro-31-8220. However, only ZO-2 protein, not ZO-1a þ , was distributed in a speckled pattern within the cytoplasm of ICMs in the presence of Gö 6983, suggesting different underlying mechanisms regulating membrane assembly of the two TJ proteins, as suggested previously (Dodane & Kachar 1996) . The ZO-2 staining pattern may, for example, represent protein storage within specific cytoplasmic regions and could suggest that degradation or transport, but not expression, of ZO-2 protein is regulated by aPKCs. ZO-1a þ , however, could be more diffusely distributed within the blastomeres by different mechanisms of protein storage or degradation, it could be less stable than ZO-2, or, indeed, its protein expression could be downregulated. Further experiments are needed to clarify this difference. A surprising observation was the stimulation of TJ membrane assembly not only upon PKC activator treatment but also upon PKC inhibition with Gö 6976. Gö 6976 reaches cPKCs just like the other three PKC inhibitors discussed above but also efficiently inhibits nPKCm. However, in our hands, PKCm localisation in isolated ICMs remained unaffected by Gö 6976. Since PKCm was predominantly found at the membrane, access of the inhibitor could have been limited or membrane anchorage could have remained unchanged (Way et al. 2000 , Slater et al. 2002 . On the other hand, relocation of aPKCi/l, an isoform not reportedly affected by this inhibitor, was prevented. Similarly, clear relocation upon PKC activator treatment indicative for activity change could be demonstrated only for PKCd and z in isolated ICMs. Although this may support the idea that nPKCs and aPKCs are involved in TJ membrane assembly, as evident particularly for aPKCs in other systems (see D'Atri & Citi 2002 , Gonzalez-Mariscal et al. 2003 , it also indicates the presence of a complex network of different mechanisms and second messengers that regulate this process in a hierarchical manner (Dodane & Kachar 1996) . The latter idea is supported by the fact that the unexpected relocation of aPKCz towards the membrane upon TPA treatment (aPKCs would not be reached directly by TPA) observed in the present study has been reported previously in neutrophils where more complex signalling through Rho GTPases and DAG-sensitive PKCs was involved in causing this relocation (Laudanna et al. 1998) . The presence of a very complex hierarchical signaling network may also be one explanation for the lack of clear effects of inhibitor and activator treatment on PKC isoform localisation in isolated ICMs. The 'switch' to induce TE-like differentiation upon provision of a contact-free cell surface by immunosurgery could not be overridden, although the ICM isolation procedure was performed in the presence of the respective inhibitor to ensure immediate effectiveness of the chemical. It must be noted, though, that although a steady-state effectiveness of various PKC inhibitors was reached within 15 min in other cell-culture systems (e.g. Staendart et al. 1997 , Lin & Chen 1998 , Keller et al. 2000 , the kinetics within the early embryo or isolated ICM remain unknown. It is, therefore, possible that the time frames of (spontaneous) relocation of specific isotypes upon provision of a contact-free cell surface and (possibly) shuttling between cell compartments might be very short. In other systems, PKC isoforms can change their distribution within minutes as a result of cellular manipulations (e.g. Nowicki et al. 2000) . Therefore, it cannot be excluded that the inhibitors might show different effects at different time points (such as minutes after ICM isolation), when intact blastocysts are pre-incubated with inhibitors for some time or when the inhibitors are used at higher dosages. However, since such treatments could provoke unwanted side effects and a loss in specificity for PKC (Beltman et al. 1996 , Morreale et al. 1997 , Lingameneni et al. 2000 , this was avoided. It must be noted that although broad chemical PKC activity modulators are useful tools to establish participation of PKC signalling, interpretation of the data obtained is difficult, in particular when a large number of PKC isoforms are available, as in the early embryo (Pauken & Capco 2000, Eckert et al. unpublished) . Insufficient or absent PKC isoform selectivity of the chemicals, variable binding efficiency that depends upon PKC localisation and accessibility, and the presence of and interference with intracellular co-factors contribute to the limitations of interpretation. More PKC isoform-specific approaches are, therefore, required to identify clearly the nature of participating PKC-signalling networks or specific isoforms that regulate certain developmental events (see Way et al. 2000 , Slater et al. 2002 .
One alternative and more selective approach to isolate individual participating PKC isoforms is to determine their localisation relative to the protein of interest. This has been used in various cell types. For example, co-localisation between PKC isoforms and TJ proteins suggests the involvement of certain PKC isotypes, particularly aPKCs, in TJ protein membrane assembly in epithelial cell models (Stuart & Nigam 1995 , Dodane & Kachar 1996 , Suzuki et al. 2001 . In our ICM model, the lack of complete colocalisation between PKC isotypes and ZO-1a þ during the membrane assembly process suggests that a permanent direct interaction between the two protein systems is not required for TJ assembly. This was suspected previously in MDCK cells (Dodane & Kachar 1996) . However, it is possible that PKCs and TJ proteins do interact during tightly regulated time periods and in certain subcellular compartments, as a newly emerging model for temporal and spatial regulation of oscillating PKC phosphorylation may suggest (Violin et al. 2003) . Our confocal data showing partial PKC and TJ co-localisation support this notion, but more rigorous biochemical analyses would be required for confirmation.
Taken together, our data showing that PKC inhibitors can, to varying extents, suppress the stimulatory effect of PKC activators on TJ protein membrane assembly, confirm a role for PKCs in this differentiation event. The data also indicate that (i) the two TJ proteins are differently regulated by PKC isotypes or subfamilies, (ii) different steps in the assembly process (reflected in different membrane and cytoplasmic staining patterns of the TJ proteins) may be separately regulated by different PKC isotypes, and (iii) from contrary effects of the different inhibitors, a role for aPKC (particularly PKCz) is implicated from the data using Gö 6983. Given the broad PKC isotype specificity of the inhibitors used, there is evidence also for a potential role for both cPKCs and nPKCs. However, since PKCd and z undergo clear relocation upon activator treatment in isolated ICMs and are differentially distributed within the TE and ICM of the nascent blastocyst (Eckert et al. unpublished), those two PKC isotypes could play a central role in regulating TJ membrane assembly.
